Hefti Erik, Quiñones-Lombraña Adolfo, Redzematovic Almedina, Hui Jeffrey, Blanco Javier G
a Department of Pharmaceutical Sciences, University at Buffalo , The State University of New York , Buffalo , NY , USA.
Mitochondrial DNA A DNA Mapp Seq Anal. 2016;27(2):896-903. doi: 10.3109/19401736.2014.926477. Epub 2014 Jun 18.
Cancer patients with Down syndrome (DS) are at increased risk for anthracycline-related cardiotoxicity. Mitochondrial DNA (mtDNA) alterations in hearts with-DS may contribute to anthracycline-related cardiotoxicity. Cardiac mtDNA and the mtDNA(4977) deletion were quantitated in samples with- (n = 11) and without-DS (n = 31). Samples with-DS showed 30% lower mtDNA (DS(MT-ND1/18Sratio): 1.48 ± 0.72 versus non-DS(MT-ND1/18Sratio): 2.10 ± 1.59; p = 0.647) and 30% higher frequency of the mtDNA(4977) deletion (DS(% frequency mtDNA(4977)) deletion: 0.0086 ± 0.0166 versus non-DS(% frequency mtDNA(4977)) deletion: 0.0066 ± 0.0124, p = 0.514) than samples without-DS. The BACH1 and microRNA-155 (miR-155) genes are located in chromosome 21, and their products have demonstrated roles during oxidative stress. BACH1 and miR-155 expression did not differ in hearts with- and without-DS. An association between BACH1 and miR-155 expression was detected in hearts without-DS, suggesting alterations between BACH1-miR-155 interactions in the DS settings.
患有唐氏综合征(DS)的癌症患者发生蒽环类药物相关心脏毒性的风险增加。患有DS的心脏中的线粒体DNA(mtDNA)改变可能导致蒽环类药物相关心脏毒性。对有DS(n = 11)和无DS(n = 31)的样本中的心脏mtDNA和mtDNA(4977)缺失进行了定量分析。有DS的样本显示mtDNA含量低30%(DS(MT-ND1/18S比率):1.48±0.72,而无DS(MT-ND1/18S比率):2.10±1.59;p = 0.647),mtDNA(4977)缺失频率高30%(DS(mtDNA(4977)缺失频率%):0.0086±0.0166,而无DS(mtDNA(4977)缺失频率%):0.0066±0.0124,p = 0.514)。BACH1和微小RNA-155(miR-155)基因位于21号染色体上,其产物在氧化应激过程中发挥了作用。有DS和无DS的心脏中BACH1和miR-155的表达没有差异。在无DS的心脏中检测到BACH1和miR-155表达之间存在关联,这表明在DS情况下BACH1-miR-155相互作用发生了改变。